본문으로 건너뛰기
← 뒤로

Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.

1/5 보강
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 📖 저널 OA 86.5% 2023: 1/1 OA 2024: 12/12 OA 2025: 148/154 OA 2026: 250/306 OA 2023~2026 2026 Vol.13(17) p. e07346
Retraction 확인
출처

Li Z, Meng C, Shen G, Shan Y, Wang J, Abudukeremu D, Zhao R, Ni B, Xu C, Guo X, Yu J, Wang K, Yang S, Li Y, Xie Y, Zhou T, Hao J, Wang X

📝 환자 설명용 한 줄

Pancreatic ductal adenocarcinoma (PDAC) remains a lethal malignancy with poor prognosis due to chemoresistance.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Li Z, Meng C, et al. (2026). Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 13(17), e07346. https://doi.org/10.1002/advs.202507346
MLA Li Z, et al.. "Mitochondrial Calcium Uniporter Drives Chemoresistance in Pancreatic Cancer via Glutathione-Mediated Stemness Maintenance.." Advanced science (Weinheim, Baden-Wurttemberg, Germany), vol. 13, no. 17, 2026, pp. e07346.
PMID 41560687 ↗

Abstract

Pancreatic ductal adenocarcinoma (PDAC) remains a lethal malignancy with poor prognosis due to chemoresistance. Using integrative single-cell RNA sequencing, we identified that the upregulation of mitochondrial calcium uniporter (MCU) may contribute to chemoresistance and stemness maintenance in PDAC. MCU was highly expressed in chemotherapy-resistant PDAC tumors and correlated with enhanced cancer stem cell properties. Mechanistically, MCU-mediated mitochondrial Ca influx triggered endoplasmic reticulum (ER) stress and the downstream PERK-eIF2α pathway. This cascade activated ATF4 and NRF2, which enhanced the transcriptional regulation of PSAT1 and SLC7A11. These changes promoted de novo glutathione (GSH) synthesis to scavenge reactive oxygen species (ROS) and sustain stemness. Genetic knockdown or pharmacological inhibition of MCU disrupted GSH synthesis, suppressed stemness, and restored sensitivity to nab-paclitaxel plus gemcitabine (AG). High-throughput screening identified MCU inhibitor NB-598, which synergized with AG to inhibit tumor growth in preclinical models. These findings offer a potential novel therapeutic strategy to address chemoresistance in PDAC.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기